What’s new. Search AllNewsInside Abselion News Sep 5, 2025 Abselion CEO Featured in BioCompare Editorial on Cell-Based Gene Therapies News Aug 28, 2025 Abselion featured in Biocompare Q&A on antibody libraries News Apr 24, 2025 NHSBT selects Amperia™ for rapid AAV vector quantification News Apr 9, 2025 Abselion Featured in IPT: Driving Protein Quantification Forward News Mar 4, 2025 Welcoming Kim Orton-Smith as VP of Sales & Marketing at Abselion News Jan 2, 2025 Oliver Hardick and Chris Major join Abselion’s new Board of Directors News Dec 4, 2024 Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser, Amperia™, to market News Sep 17, 2024 Abselion welcomes Anne Jones as Non-Executive Director News Aug 20, 2024 International consortium to revolutionize viral vector manufacturing News Dec 8, 2023 Abselion wins prize for next generation analytical tool at the BIA Bioprocess UK conference 2023! Inside Abselion Aug 4, 2023 Meet Abselion News Oct 20, 2021 Abselion Wins SLAS Innovation AveNEW Top Startup Award Load More Follow us on LinkedIn for latest news & updates.
News Dec 4, 2024 Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser, Amperia™, to market
News Dec 8, 2023 Abselion wins prize for next generation analytical tool at the BIA Bioprocess UK conference 2023!
